This article is part of Bain’s 2024 Global Private Equity Report
It’s safe to say the private equity industry has never seen anything quite like what’s happened over
Diversity has long been a goal of businesses, universities, and communities. In addition to providing basic fairness to those who might otherwise be shut out, a diversity of experiences and points of
The Indian tech startup ecosystem is currently navigating a significant transition where mature software sectors (primarily non-DeepTech) continue to attract steady capital while strategically vital sectors like DeepTech face a widening gap
Conditions for global private markets were decidedly mixed in 2024. Dealmaking remained tepid, for instance, while fundraising across all asset classes fell to its lowest level since 2016, even as the performance
GenAI VC funding up 65% year-on-year to $87 billion – 350% above 2023 levels Sovereign wealth funds emerge as major players, investing $46 billion in AI ventures Deal volumes down 35% year-on-year
Executive summary India’s private equity (PE) market entered a disciplined phase in 2025, marked by a sharp slowdown in large-cap dealmaking and a shift toward more selective, value-creation-focused investing. Total private equity
Looking ahead to Q2’26, geopolitical developments, particularly ongoing conflicts and their impact on energy prices and inflation, will be key factors shaping VC sentiment. AI is expected to remain the strongest area
There is no guarantee that research capabilities will contribute to a positive investment outcome. Systematic Investment Process Video Script Systematic investment process [Title card] The world is more data-driven than ever before.
Venture capital (VC) is the lifeblood of innovation in healthcare, propelling advancements that drive progress. Despite its critical role, it often feels like an exclusive club with its own set of mysteries.
This document has been issued by HSBC Bank plc, which has based this document on information obtained from sources it believes to be reliable but which it has not independently verified. Neither
Cushman & Wakefield’s latest life sciences market report External Link breaks down the major trends shaping the industry, from resurgent capital markets and accelerated dealmaking to how real estate is performing across established hubs